Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 55

ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury

Official title: Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)

Run by Johns Hopkins University · NCT07890337 · Data updated 2026-11-12

This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment30 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedOctober 2026
Main results expectedMay 2027
Study endsMay 2028
Registry record updatedOctober 26, 2026
Trial IDNCT07890337 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults up to age 55 with a history of one or more concussions and mild-to-moderate PTSD symptoms (DTS 20–44) who are already receiving or have recently received standard care for mTBI or PTSD.

Probably not a fit

Individuals with severe psychiatric disorders, active substance abuse, epilepsy or other major neurological diseases, or age above 55 may not benefit or participate safely.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 1 trial investigates an integrated treatment that blends virtual reality exposure with standard psychotherapy for adults who have mild traumatic brain injury and PTSD symptoms. Participants will receive VR-based interventions alongside ongoing psychotherapeutic care to target hyperarousal and hypervigilance. The study uses the Davidson Trauma Scale to measure changes in PTSD symptoms, particularly hyperarousal. Recruitment is limited to adults with a history of concussion and current PTSD symptoms, who are receiving or have recently received evidence-based treatments. The research is conducted at Johns Hopkins Bayview Medical Center in Baltimore, under Johns Hopkins University as lead sponsor.

Why it matters

Potential benefit: If successful, participants may experience reductions in PTSD symptoms and improvements in cognitive and emotional regulation related to mTBI.

How similar studies have gone: Prior research suggests that VR-assisted therapies and exposure-based approaches can reduce PTSD symptoms in related populations, supporting exploration of this combined modality.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* History of one or more concussions.
* Presence of mild-to-moderate PTSD symptoms, defined as a score between 20 and 44 on the Davidson Trauma Scale (DTS), indicating clinically relevant but not severe symptomatology (Davidson et al., 1997).
* Prior or ongoing therapy, defined as current or recent (within the last 3 months) engagement in standard care treatments such as psychiatric medication management, and evidence-based psychotherapy targeting mTBI or PTSD symptoms.
* Prior U.S military service (any duration and any branch) is required for eligibility.

Exclusion criteria:

* Age over 55 to reduce confounding effects of age-related neurodegeneration and cognitive decline.
* Diagnosis of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder).
* Active substance abuse.
* Presence of unrelated neurological conditions such as epilepsy, stroke, seizure disorders, or neurodegenerative diseases (e.g., Alzheimer's, Parkinson's).
* Significant cognitive impairment, assessed by standardized cognitive screening, which would interfere with the ability to participate fully in VR and therapy sessions.
* Physical impairments that would prevent safe engagement in VR and therapy.

Where it's running

  • Johns Hopkins Bayview Medical Center - Pyschiatry
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Durga Roy, MD — Johns Hopkins University
  • Study coordinator: Saumik Das
  • Email: sdas41@jh.edu
  • Phone: 703-554-0332

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.